Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Quanterix Corp (QTRX)
Sector: Healthcare; Industry: Medical Devices

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-03 HRUSOVSKY E KEVIN Chairman and CEO Sell 3,715 $41.91 $155,683 No
2021-12-29 Duffy David C. SVP R&D and CTO Sell 1,667 $40.71 $67,864 No
2021-12-01 HRUSOVSKY E KEVIN Chairman and CEO Sell 3,710 $40.29 $149,477 No
2021-12-01 Roskey Mark T. SVP, Strategic Partnerships Sell 147 $40.29 $5,923 No
2021-12-01 Mattoon Dawn Sr. VP, Diagnostics Sell 353 $40.29 $14,222 No
2021-12-01 Fry John J General Counsel & Secretary Sell 350 $40.29 $14,101 No
2021-11-19 Duffy David C. SVP R&D and CTO Sell 1,667 $45.54 $75,915 No
2021-11-10 HRUSOVSKY E KEVIN Chairman and CEO Sell 5,000 $55.18 $275,897 No
2021-11-05 Mattoon Dawn Sr. VP, Diagnostics Sell 8,536 $57.28 $488,908 Yes
2021-11-02 Roskey Mark T. SVP, Strategic Partnerships Sell 139 $52.61 $7,312 No
2021-11-02 Mattoon Dawn Sr. VP, Diagnostics Sell 333 $52.61 $17,518 No
2021-11-02 Fry John J General Counsel & Secretary Sell 331 $52.61 $17,412 No
2021-10-22 HRUSOVSKY E KEVIN Chairman and CEO Sell 5,000 $50.70 $253,520 No
2021-10-15 Duffy David C. SVP R&D and CTO Sell 1,667 $51.47 $85,800 No
2021-10-01 Roskey Mark T. SVP, Strategic Partnerships Sell 143 $51.20 $7,322 No
2021-10-01 HRUSOVSKY E KEVIN Chairman and CEO Sell 8,594 $49.97 $429,464 No
2021-09-01 Roskey Mark T. SVP, Strategic Partnerships Sell 147 $49.92 $7,338 No
2021-09-02 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 8,709 $49.77 $433,464 No
2021-08-16 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 5,000 $47.33 $236,669 No
2021-08-03 Roskey Mark T. SVP, Strategic Partnerships Sell 145 $53.79 $7,799 No
2021-07-02 Mattoon Dawn Sr. VP, Diagnostics Sell 9,497 $58.84 $558,797 Yes
2021-06-23 Duffy David C. SVP R&D and CTO Sell 1,667 $62.11 $103,537 No
2021-06-14 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 5,000 $66.01 $330,052 No
2021-06-07 Mattoon Dawn Sr. VP, Diagnostics Sell 13,549 $59.46 $805,623 Yes
2021-06-07 DEKKERS MARIJN E Director Sell 16,661 $55.52 $925,077 Yes
2021-06-02 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 8,854 $48.83 $432,303 No
2021-06-01 Roskey Mark T. SVP, Strategic Partnerships Sell 153 $48.32 $7,393 No
2021-06-01 Mattoon Dawn Sr. VP, Diagnostics Sell 243 $48.32 $11,741 No
2021-05-28 Duffy David C. SVP R&D and CTO Sell 1,667 $51.00 $85,017 No
2021-05-13 HRUSOVSKY E KEVIN Chairman, President & CEO Sell 5,000 $46.30 $231,491 No

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.